How to medical device prototyping?

Here’s a practical, step-by-step guide to medical device prototyping, based on real-world practices used by startups, established medtech companies, and regulatory consultants. This process balances speed, cost, safety, and eventual regulatory compliance (ISO 13485, FDA 21 CFR 820, EU MDR).

Phase 1: Define Requirements & Risk Early (Most Important, Often Skipped)

• Write a short Product Requirement Document (PRD) 

• Intended use, user needs, target patient population  

• Clinical claims (diagnostic, therapeutic, monitoring, etc.)  

• Risk classification (FDA Class I, IIa, IIb, III or EU MDR Class I, IIa, IIb, III)

• Perform preliminary risk management (ISO 14971)  

• Identify hazards (electrical, biological, usability, etc.)  

• This drives almost every material and design decision later.

Phase 2: Concept Prototyping (Proof-of-Concept, “Looks-Like” + “Works-Like”)

• Goal: Validate the core technical principle cheaply and fast.

Phase 3: Alpha Prototypes (Integrated, “Works-Like + Looks-Like”)

Common methods:

• High-end 3D printing  

• CNC machining (aluminum, PEEK, titanium) for metal parts

• Custom PCBs (KiCad → JLCPCB or domestic fab for speed)

• Silicone overmolding (Smooth-On Dragon Skin or biocompatible equivalents) for soft parts

• Rapid injection molding (Protolabs, Xometry “on-demand molding”) – 5–25 parts in real material

Phase 4: Beta / “Design Freeze” Prototypes

• Looks and functions essentially like production.

• Use production-intent processes whenever possible 

• Build 20–100 units (depends on class and risk)

• Perform formal verification & validation (V&V) 

Phase 5: Pilot Production & Design Transfer

• Final design locked → Design History File (DHF) complete

• Process validation (IQ/OQ/PQ) for critical processes

• First clinical investigation or 510(k)/De Novo/PMA submission package

Recommended Toolchain (2025)

Critical Regulatory Tips for Prototyping

• Document everything in your Design Controls (even for prototypes) — FDA will ask for it.

• If you ever touch a human or animal, you need IRB/IEC approval and documented biocompatibility (ISO 10993).

• Keep a “prototype log” — what changed and why — this becomes your design history.

• Avoid “clinical use” of non-sterile, non-biocompatible prototypes — huge regulatory red flag.